Combined threshold pressure respiratory muscle training plus targeted iTBS for improving breathing after spinal cord injury
Official title: The Effect of Threshold Pressure-loaded Respiratory Muscle Training Combined With Transcranial Intermittent Theta Burst Stimulation on Respiratory Function in Patients With Spinal Cord Injury
Run by Shengjing Hospital · NCT07050069 · Data updated 2026-11-12
This will test whether daily breathing muscle training combined with targeted intermittent theta-burst stimulation (iTBS) helps people with recent spinal cord injuries breathe better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Shengjing Hospital Academic / other |
| Locations | 1 site (Shenyang, Liaoning) |
| Status | Recruiting |
| Started | December 25, 2024 |
| Main results expected | December 25, 2025 |
| Study ends | December 25, 2025 |
| Registry record updated | July 3, 2025 |
| Trial ID | NCT07050069 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–80 with a confirmed spinal cord injury at T12 or above, AIS grade A–C, 2 weeks to 6 months after injury, who can give informed consent are the intended participants.
✕Probably not a fit
Patients who are ventilator-dependent, have unstable vital signs, severe cardiorespiratory disease, or contraindications to magnetic stimulation are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will compare threshold pressure-load respiratory muscle training, intermittent theta-burst stimulation (iTBS) over the diaphragm cortical projection, and the two combined to determine which approach best improves respiratory function in people with spinal cord injury. Participants receive the assigned intervention daily for four weeks and attend hospital visits every two weeks for checks and respiratory testing. Symptoms and objective respiratory measures will be recorded before, during, and after the intervention to track changes. The trial enrolls adults 18–80 with imaging-confirmed SCI at T12 or above, AIS grade A–C, 2 weeks to 6 months post-injury, and excludes those with contraindications to magnetic stimulation or who require mechanical ventilation.
Why it matters
Potential benefit: If successful, the combined treatment could strengthen breathing muscles and reduce respiratory complications for people with recent spinal cord injuries.
How similar studies have gone: Respiratory muscle training and noninvasive brain stimulation have shown promise individually in prior work, but combining threshold-load training with targeted iTBS for diaphragm function is relatively novel and not yet well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with spinal cord injury (SCI) meeting the 2019 revised International Standards for Neurological Classification of Spinal Cord Injury by the American Spinal Injury Association (ASIA), confirmed by CT/MRI. * Aged 18-80 years. * Time since injury: 2 weeks to 6 months, with spinal shock resolved. * Injury level at T12 or above, ASIA Impairment Scale (AIS) grade A-C. * Patients providing written informed consent after study explanation. Exclusion Criteria: * Patients with severe cardiorespiratory diseases (e.g., pneumothorax). * Unstable vital signs (e.g., hypotension, arrhythmia). * Cognitive/psychiatric disorders precluding cooperation. * Requiring mechanical ventilation. * Congenital spinal/limb deformities. * Contraindications to magnetic stimulation: intracranial metal implants, pacemakers, etc.
Where it's running
-
Rehabilitation Center of Shengjing Hospital, China Medical University
Shenyang, Liaoning, China Recruiting
Study contacts
- Principal investigator: Jiang Xue — Rehabilitation Center of Shengjing Hospital, China Medical University
- Study coordinator: Jiang Xue
- Email: jiangxueruby@163.com
- Phone: +86 18940254064
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transcutaneous spinal cord stimulation with 4-aminopyridine and intensive rehab for chronic spinal cord injury
This pilot study tests whether combining noninvasive spinal stimulation, dalfampridine, and rigorous rehab is safe and feasible for adults with chronic spinal cord injury and whether it can help improve movement and walking.
-
NG004 for incomplete cervical spinal cord injury
This trial tests NG004 versus placebo to see if it is safe and helps motor function and daily life in adults with acute incomplete cervical spinal cord injury.
-
Robot-assisted training for arm and leg movement after stroke or injury
This study tests whether adding ZEPU-AI robotic training to usual therapy is safe and helps adults with arm or leg movement problems from stroke, spinal cord injury, brain injury, or orthopedic conditions.
-
ZEPU-AI3 Lower Limb Feedback Training and Evaluation Robot in Rehab
This pilot trial tests whether adding the ZEPU-AI3 robotic leg training with real-time feedback to standard rehab helps adults with lower limb motor problems from stroke, spinal cord injury, or similar conditions.
-
Combined magnetic stimulation and ultrasound for detrusor overactivity in spinal cord injury
This study tests whether using high-frequency sacral nerve stimulation together with bladder-directed ultrasound can reduce involuntary bladder contractions and improve bladder function in people with spinal cord injury.
-
Hybrid HIIT-FES cycling program for people with spinal cord injury
This study tests a hybrid exercise program that combines functional electrical stimulation cycling with voluntary arm work to improve health in adults with spinal cord injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.